Whitehawk Therapeutics (WHWK) Accounts Payables (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Accounts Payables of $1.7 million for Q1 2026, down 52.28% year-over-year from $3.7 million in Q1 2025, and up 90.29% on a QoQ basis from $917000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Accounts Payables data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Accounts Payables fell 52.28% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 52.28% YoY) and the FY2025 annual result came in at $917000.0, down 57.53% from the prior year.
- Accounts Payables climbed to $1.7 million in Q1 2026 per WHWK's latest filing, from $917000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $6.5 million in Q1 2023 and bottomed at $917000.0 in Q4 2025.
- The 5-year median for Accounts Payables is $3.1 million (2024), against an average of $3.1 million.
- The widest annual swing landed in 2022, when Accounts Payables soared 774.29%; it then sank 63.39% in 2024.
- Tracing WHWK's Accounts Payables over 5 years: stood at $3.5 million in 2022, then surged by 67.6% to $5.9 million in 2023, then slumped by 63.39% to $2.2 million in 2024, then slumped by 57.53% to $917000.0 in 2025, then soared by 90.29% to $1.7 million in 2026.
- Per Business Quant, the three latest WHWK Accounts Payables figures stand at $1.7 million (Q1 2026), $917000.0 (Q4 2025), and $1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 917,000.00 |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 6.51 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 3.62 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 6.44 Mn |
| Sep 30, 2021 | 5.21 Mn |
| Jun 30, 2021 | 746,880.00 |
| Mar 31, 2021 | 458,658.00 |
| Dec 31, 2020 | 2.39 Mn |
| Sep 30, 2020 | 2.42 Mn |
| Jun 30, 2020 | 622,658.00 |
| Mar 31, 2020 | 2.55 Mn |
| Dec 31, 2019 | 439,785.00 |
| Sep 30, 2019 | 3.40 Mn |
| Jun 30, 2019 | 3.40 Mn |
| Mar 31, 2019 | 3.73 Mn |
| Dec 31, 2018 | 595,680.00 |
| Sep 30, 2018 | 717,000.00 |
| Jun 30, 2018 | 2.97 Mn |
| Mar 31, 2018 | 1.63 Mn |
| Dec 31, 2017 | 1.28 Mn |
| Sep 30, 2017 | 2.59 Mn |
| Jun 30, 2017 | 782,169.00 |
| Mar 31, 2017 | 1.87 Mn |
| Dec 31, 2016 | 2.47 Mn |
| Sep 30, 2016 | 2,087.00 |
| Jun 30, 2016 | 10,189.00 |
| Mar 31, 2016 | 8,036.00 |
| Dec 31, 2015 | 3,674.00 |
| Sep 30, 2015 | 2,502.00 |
| Jun 30, 2015 | 1,999.00 |
| Mar 31, 2015 | 10,088.00 |
| Dec 31, 2014 | 2,402.00 |
| Sep 30, 2014 | 10,682.00 |
| Jun 30, 2014 | 8,155.00 |
| Mar 31, 2014 | 713.00 |
| Dec 31, 2013 | 350.00 |
| Sep 30, 2013 | 650.00 |
| Jun 30, 2013 | 175.00 |
| Mar 31, 2013 | 6,380.00 |
| Dec 31, 2012 | 1,850.00 |
| Sep 30, 2012 | 633.00 |
| Jun 30, 2012 | 175.00 |
| Mar 31, 2012 | 3,806.00 |
| Dec 31, 2011 | 2,977.00 |
| Sep 30, 2011 | 2,567.00 |
| Jun 30, 2011 | 2,200.00 |
| Dec 31, 2010 | 2,165.00 |